EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future

Ahmed Hassanein, Saghir Akhtar

Biomolecules and Biomedicine · 19.03.2025 · 26 (1) · 5-23

DOI: 10.17305/bb.2025.12222 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 19.03.2025. Verfasst von Ahmed Hassanein und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, QU Health, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Stem Cell Transplantation, Stem Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes mellitus (T1DM) is a serious, chronic metabolic and autoimmune disease that affects millions globally. While insulin administration remains the most effective treatment, it is not a cure. Long-term therapies, such as immunotherapy, can be effective for some patients, but they have notable limitations and do not provide a permanent solution. As a result, current research has shifted towards stem cell-based therapies, which offer a potentially expandable and scalable source of pancreatic beta cells. These therapies aim to restore long-term endogenous β-cell function in all T1DM patients, provided they can avoid immune recognition and rejection by the host. In this review, we will discuss the latest first-in-human successes of stem cell therapies for T1DM. We will then explore stem cell-derived islet encapsulation technologies and hypoimmune stem cells, examining how they might overcome the need for immunosuppressive therapy. Additionally, we will provide a summary of recent and ongoing biopharmaceutical industry pipelines and clinical trials for stem cell therapies aimed at treating T1DM. These advances suggest that stem cell therapies offer a promising and highly effective approach to treating patients with this chronic disease. However, large-scale clinical trials over the long term are necessary to verify these early successes and assess the curative potential of stem cell therapy for T1DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Stem Cell TransplantationStem CellsHumansInsulin-Secreting CellsAnimals

Autor:innen und Institutionen

  • College of Medicine, QU Health, Qatar University, Doha, Qatar.

Zitieren

APA

Hassanein, A., & Akhtar, S. (2025). Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future. Biomolecules and Biomedicine, 26(1), 5-23. https://doi.org/10.17305/bb.2025.12222

Vancouver

Hassanein A, Akhtar S. Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future. Biomolecules and Biomedicine. 2025;26(1):5-23. doi:10.17305/bb.2025.12222

BibTeX
@article{Hassanein2025,
  author = {Hassanein, Ahmed and Akhtar, Saghir},
  title = {Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {5--23},
  doi = {10.17305/bb.2025.12222}
}
Kostenlos starten →